About MileCell
Premium Primary Cell Solutions for Global Drug Discovery
At MileCell, we are dedicated to advancing life science research through innovative, dependable, and biologically relevant tools. We understand the complexities of cellular studies and are committed to providing high-quality products that enable researchers to achieve consistent, reproducible results.
Specializing in premium primary cells, optimized culture media, high-performance cryopreservation systems, and cutting-edge magnetic bead technologies for gentle and reliable immune cell isolations, we deliver solutions designed to support the full spectrum of in vitro research needs.
Guided by our mission to provide integrated, primary cell-based solutions, we partner with scientists worldwide to drive discovery and accelerate the development of safer, more effective therapies. From immune and hepatic models to CGT-ready cryopreservation media, MileCell provides the essential tools needed to generate meaningful data and move new therapies forward-faster and with greater confidence.
Established in
R&D and Production Facility
Research Programs Supported
Primary Cell Types
MileCell
A company dedicated to providing innovative, reliable and biologically relevant tools and integrated solutions for life science research.
MileCell Business Scope
Specializing in premium primary cells, advanced culture media, high-performance cryopreservation systems, and cutting-edge magnetic bead technologies for gentle and reliable immune cell isolation, we deliver solutions designed to support the full spectrum of in vitro research needs.
Subcellular Fractions
Cell Freezing Media
Immune Cell Isolation Magnetic Bead
Our Mission & Vision
Mission:
To empower life science research with high-quality, biologically relevant cell-based solutions that enable reliable discovery and accelerate the development of better therapies.
Vision:
To build a global platform where better biological models enable better science-and ultimately, better therapies.
Our History
2014
Established
Development of primary cells from multiple tissue sources: Peripheral blood, umbilical cord, liver and skin.
2017
2020
R&D commercialization cell production base buildup. Develop a variety of cell-related reagents
Expanded Immune & Liver Cells product lines, Cryopreservation Media & Culture Media commercialized
2023
